Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/172406| Title: | Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis |
| Author: | Montes Moreno, Santiago Batlle, Ana González de Villambrosía, Sonia Sánchez-Espiridión, Beatriz Cereceda, Laura González Barca, Eva Purroy, Noelia Pardal, Emilia Martín, Alejandro Grande, Carlos Mazorra, Francisco Insunza, Andrés Quero, Cristina Aguiar, David Cruz, Miguel Ángel Rueda Dominguez, Antonio Llanos, Marta Gómez Codina, Jose García Arroyo, Francisco Ramón Caballero, Dolores Conde, Eulogio López, Andres Provencio, Mariano Piris, Miguel A. |
| Keywords: | Quimioteràpia Limfomes Cèl·lules B Diagnòstic Cèl·lules mare Chemotherapy Lymphomas B cells Diagnosis Stem cells |
| Issue Date: | 1-Aug-2014 |
| Publisher: | Ferrata Storti Foundation |
| Abstract: | Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous disease entity. Young patients with high-intermediate and high aa-IPI score seem to be good candidates to receive alternative treatments to standard RCHOP-21 including EPOCH-R,2 R-ACVBP+HDT-ASCT3 and upfront autologous stem cell transplantation. Other risk factors can be used to identify patients for the use of more doseintense regimens including bulky disease, interim PET positivity and, importantly, molecular profiles. |
| Note: | Reproducció del document publicat a: https://doi.org/10.3324/haematol.2014.104976 |
| It is part of: | Haematologica, 2014, vol. 99, num. 8, p. 138-141 |
| URI: | http://hdl.handle.net/2445/172406 |
| Related resource: | https://doi.org/10.3324/haematol.2014.104976 |
| ISSN: | 0390-6078 |
| Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 679858.pdf | 196.73 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.